Target intelligence / Profile preview

Immunoglobulin heavy variable 3-19 (IGHV3-19)

Target
IGHV3-19
Molecular classification
Immunoglobulin heavy chain variable region, Immunoglobulin superfamily (IgSF)
01

Overview

IGHV3-19 encodes a variable region segment of the immunoglobulin heavy chain, integral to the generation of antibody diversity through V(D)J recombination in B cells. Its protein product forms part of the antigen-binding site in the immunoglobulin structure, contributing to the specific recognition of antigens and playing a central role in humoral immunity. While many IGHV genes are studied for their role in generating functional antibodies, IGHV3-19 is not widely characterized or specifically linked to therapeutic or biomarker roles. It serves primarily as a genetic element underlying the adaptive immune response, with importance in antibody structural diversity and population-level immunogenetic variation[1][2][3].

Other names
3-19PIGHV319IGHV3-19
02

Mechanism of action

None directly. IGHV3-19 contributes to the antigen-binding site of immunoglobulins, which when incorporated into specific monoclonal antibodies, may mediate neutralization of pathogens or modulation of immune responses[2]. No drugs act directly on IGHV3-19.

03

Biological functions

Antigen recognitionImmune response (humoral immunity)
04

Disease associations

Other (antibody variants may be relevant in infection, cancer, autoimmune disease depending on repertoire; no specific disease association for this segment[2])

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-19 (IGHV3-19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-19 (IGHV3-19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call